Bidirectional alpha collapse, not forward wave increase, under N,N-DMT: A reanalysis of cortical travelling waves
Zenodo (CERN European Organization for Nuclear Research) April 2, 2026 DOI: 10.5281/zenodo.19390558 via OpenAlex
Summary
AI-generated from the abstractReanalysis of a prior study on DMT's effect on brain waves shows that the drug does not selectively increase forward (bottom-up) traveling waves. Instead, DMT causes a collapse of both forward and backward wave power at alpha (8–13 Hz) and broadband (2–100 Hz) frequencies in all 12 subjects. The backward collapse is slightly larger (2.3–5.1 percentage points). The earlier reported increase in normalized forward power was an artifact of the surrogate baseline dropping faster than the signal. At the peak effect, forward and backward alpha power were statistically indistinguishable, and the forward signal did not significantly differ from zero. The brain's directional wave structure under DMT is lost rather than reorganized.
Study at a glance
| Characteristics | Reanalysis Peer reviewed |
|---|---|
| Sample size | 12 |
| Population | Human participants in a publicly available EEG dataset |
| Interventions | N N-dimethyltryptamine (DMT) |
| Keywords | Power physics Amplitude Traveling wave Convergence economics Fast fourier transform |
| Key finding | DMT does not increase forward cortical traveling waves but instead causes a bidirectional collapse of wave power with loss of detectable directional structure at alpha frequencies. |
Abstract
Alamia et al. (2020) reported that N,N-dimethyltryptamine (DMT) significantly increases forward (bottom-up) cortical travelling waves, based on surrogate-normalized 2D FFT analysis. We reanalyze the same publicly available EEG dataset (N = 12) using the same method, supplemented by absolute power analysis. Absolute forward wave power decreases under DMT in all 12 subjects at alpha (8–13 Hz) and 11 of 12 at broadband (2–100 Hz); placebo produces no significant change in absolute power. Both forward and backward power collapse bidirectionally, with backward collapsing significantly more (2.3–5.1 percentage points, all p ≤ 0.002, 12/12 subjects at alpha). This differential persists in within-subject percentage changes, which inherently normalize each direction to its own baseline. The apparent normalized forward “increase” arises because the surrogate baseline inherits the spectral collapse and drops faster than the forward signal. Forward dB at the maximum measured effect was not significantly above zero (Bayes factor BF01 = 2.45, Jeffreys–Zellner–Siow prior r = √2/2; Rouder et al., 2009), providing anecdotal evidence for convergence to the surrogate null rather than emergence of new directional activity. At the maximum measured effect, absolute forward and backward alpha power were statistically indistinguishable (p = 0.27), consistent with both directions collapsing to a common floor. The electrophysiological signature of DMT is better described as bidirectional wave power collapse with loss of detectable directional structure at alpha frequencies than as directional reorganization.